Staege M S, Dick T, Reske-Kunz A B
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany.
Cell Immunol. 1996 Jul 10;171(1):62-7. doi: 10.1006/cimm.1996.0173.
The cytotoxic T cell clone 10BK.1 is activated in response to the ovalbumin peptide OVA257-264 in a major histocompatibility complex class I-restricted manner. Following activation 10BK.1 cells proliferate, secrete lymphokines, and kill syn- and allogeneic target cells. Using immunofluorescence analysis we detected CD8, LFA-1, and ICAM-1 on the surface of 10BK.1 cells, but no CD3 or T cell receptor (TCR). In contrast, the proliferative response of 10BK.1 cells to antigen was efficiently blocked by soluble antibodies directed at CD3 epsilon or TCR alpha beta, but not by antibodies directed at TCR gamma delta. In addition, lysis of target cells was blocked by F(ab')2 fragments of antibodies directed at CD3 epsilon, and 10BK.1 cells proliferate in response to immobilized anti-CD3 epsilon or anti-TCR alpha beta antibodies. Furthermore, 10BK.1 cells lyse hybridoma cells that secrete antibodies directed at CD3 epsilon or TCR alpha beta, but not TCR gamma delta. These results demonstrate that functionally active molecules of the TCR/CD3 complex exist on the surface of 10BK.1 cells, obviously in low amounts, undetectable by immunofluorescence. In contrast, using permeabilized cells, we found high cytoplasmatic expression of TCR alpha beta, CD3 epsilon, and zeta-chain in 1OBK.1 cells, indicating that the low level of TCR/CD3 expression on the surface is not a consequence of a reduced synthesis of these molecules, but that the transport of these molecules to the surface is reduced. Our data demonstrate that the absence of TCR/CD3 complexes on the surface of cells, as detected by immunofluorescence, does not warrant the conclusion that these complexes are also functionally absent from the surface of these cells.
细胞毒性T细胞克隆10BK.1以主要组织相容性复合体I类限制的方式对卵清蛋白肽OVA257 - 264产生应答而被激活。激活后,10BK.1细胞增殖、分泌淋巴因子并杀伤同基因和异基因靶细胞。通过免疫荧光分析,我们在10BK.1细胞表面检测到了CD8、淋巴细胞功能相关抗原-1(LFA - 1)和细胞间黏附分子-1(ICAM - 1),但未检测到CD3或T细胞受体(TCR)。相反,针对CD3ε或TCRαβ的可溶性抗体可有效阻断10BK.1细胞对抗原的增殖反应,而针对TCRγδ的抗体则无此作用。此外,针对CD3ε的抗体F(ab')2片段可阻断靶细胞的裂解,并且10BK.1细胞对固定化的抗CD3ε或抗TCRαβ抗体产生增殖反应。此外,10BK.1细胞可裂解分泌针对CD3ε或TCRαβ而非TCRγδ抗体的杂交瘤细胞。这些结果表明,TCR/CD3复合体的功能活性分子存在于10BK.1细胞表面,显然数量很少,免疫荧光检测不到。相反,使用通透化细胞,我们发现10BK.1细胞中TCRαβ、CD3ε和ζ链在细胞质中有高表达,这表明表面TCR/CD3表达水平低并非这些分子合成减少的结果,而是这些分子向表面的转运减少。我们的数据表明,通过免疫荧光检测到细胞表面不存在TCR/CD3复合体,并不足以得出这些复合体在这些细胞表面也无功能的结论。